Trasylol (aprotinin injection)

November 7, 2007 by RecallAware
Filed under: Uncategorized 

Marketing suspension of Trasylol announced, pending detailed review of preliminary results from a Canadian study that suggested an increased risk for death.

Tags:

Comments

Readers of this site appreciate your comments

You must be logged in to post a comment.

References and links to other sites are provided as a courtesy. The recall and safety information provided here is based entirely on manufacturers' and regulatory agencies' press release or other public information. We make no other representations about the accuracy or timeliness of this information